LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 39 filers reported holding LYRA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perceptive Advisors | 3,222,560 | $12,955,000 | 0.26% |
Ikarian Capital, LLC | 422,338 | $1,698,000 | 0.22% |
PURA VIDA INVESTMENTS, LLC | 520,544 | $2,093,000 | 0.07% |
Clearline Capital LP | 119,924 | $482,000 | 0.06% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 66,900 | $269,000 | 0.01% |
BOOTHBAY FUND MANAGEMENT, LLC | 38,516 | $155,000 | 0.00% |
Pentwater Capital Management LP | 60,000 | $241,000 | 0.00% |
Worth Asset Management, LLC | 650 | $3,000 | 0.00% |
Close Asset Management Ltd | 7,000 | $30,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 82,200 | $330,000 | 0.00% |